Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

News

Systematic review found that non-invasive positive pressure ventilation may reduce hospital mortality in people with acute cardiogenic pulmonary oedema

This Cochrane systematic review evaluated the effectiveness and safety of non-invasive positive pressure ventilation compared to standard care for adults with acute cardiogenic pulmonary oedema. Randomised controlled trials recruiting participants aged 18 years and older with a diagnosis of acute cardiogenic pulmonary oedema that evaluated nasal or face mask non-invasive positive pressure ventilation (continuous positive airway pressure, bilevel non-invasive positive pressure ventilation, or both) were included. Cross-over and cluster trials were excluded. The primary outcome was hospital mortality. Secondary outcomes included endotracheal intubation, incidence of acute myocardial infarction during hospitalisation, after starting treatment. The quality of the evidence was assessed using the GRADE approach.

24 trials (n = 2,664 participants) were included. Most trials were conducted in emergency departments or intensive care units. The mean age of the population was 73 (SD 9) years. There was low-quality evidence that non-invasive positive pressure ventilation may reduce hospital mortality compared to standard care (relative risk 0.65, 95% confidence interval (CI) 0.51 to 0.82; n = 2,484 participants; number needed to treat = 17). There was moderate quality evidence that non-invasive positive pressure ventilation probably reduces endotracheal intubation rates (RR 0.49 95% CI 0.38 to 0.62; n = 2,449 participants; number needed to treat = 13). There was moderate quality evidence that non-invasive positive pressure ventilation probably does not reduce the incidence of acute myocardial infarction compared to standard care (RR 1.03 95% CI 0.91 to 1.16; n = 1,313 participants; number needed to treat = 5). The use of non-invasive positive pressure ventilation in patients with acute cardiogenic pulmonary oedema may reduce mortality and probably reduces the risk of endotracheal intubation.

Berbenetz N et al. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema. Cochrane Database Syst Rev 2019;Issue 4

Read more on PEDro.

Sign up to the PEDro Newsletter to receive the latest news